Anew tissue engineering company would like to use autologous cell- seeded scaffolds as implants for the engineering of a few different joint tissues including cartilage, ligament, and bone. one of the company’s consultants has recommended that the company invest in technologies to isolate chondrocytes from cartilage, ligament cells from ligament, and osteoblasts from bone so that cells can be grown individually in culture to increase their number before being seeded into scaffolds. what are the advantages and disadvantages of the consultant's recommendation?